DRUG USER FEE GOALS BEING EXCEEDED "SIGNIFICANTLY," ACCORDING TO LATEST FIGURES, COMMISSIONER KESSLER TELLS FDLI; ALL BACKLOGS ACTED ON AS OF JULY 2
Executive Summary
Prescription drug user fee goals set by the 1992 law designed to improve approval times at FDA through FY 1997 are being "significantly" exceeded, FDA Commissioner Kessler said during his "State of the FDA" speech at the Food & Drug Law Institute annual conference in Washington, D.C. Dec. 12.